Biological treatment patterns in patients with inflammatory joint diseases. Retrospective study with 4 years follow-up Juan D. Cañete, Antonio Naranjo, Javier Calvo, Carmen Ordás, Belén Aragón, Gonzalo Nocea, Montse Roset, Antonio Fernández-Nebro

Anti-TNFα therapy in ankylosing spondylitis: symptom control and structural damage modification José Luis Andreu, Teresa Otón, Jesús Sanz

Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease? Fatih Albayrak, Mustafa Gür, Ahmet Karataş, Süleyman Serdar Koca, Bünyamin Kısacık